Parthenolide
Clinical trialMechanism of Action
Research Notes
Parthenolide is the primary bioactive in feverfew, with clinical evidence for migraine prophylaxis and inflammatory conditions. Demonstrates broad anti-inflammatory action through NF-κB pathway inhibition, relevant for musculoskeletal pain management.
Parthenolide is the primary bioactive sesquiterpene lactone in the closely related feverfew (Tanacetum parthenium), where it has been validated in multiple RCTs for migraine prophylaxis. In tansy, parthenolide content is variable (0.01–0.5% depending on chemotype). In vitro studies show potent NF-κB inhibition with IC50 ~1 µM and selective cytotoxicity against leukemia stem cells (Guzman et al., 2005, Blood).
Found In 2 Herbs
3D Molecular Structure
Parthenolide
Representative pattern: C₂₁H₃₀O₂
Live Research
This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare practitioner before using any herbal product.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This content is for educational purposes only and is not a substitute for professional medical advice.

